BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 18281510)

  • 1. DNAzyme technology and cancer therapy: cleave and let die.
    Dass CR; Choong PF; Khachigian LM
    Mol Cancer Ther; 2008 Feb; 7(2):243-51. PubMed ID: 18281510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNAzymes as potential therapeutic molecules.
    Isaka Y
    Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNAzymes: from creation in vitro to application in vivo.
    Achenbach JC; Chiuman W; Cruz RP; Li Y
    Curr Pharm Biotechnol; 2004 Aug; 5(4):321-36. PubMed ID: 15320762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
    Lam JC; Withers JB; Li Y
    J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNAzymes: cutting a path to a new class of therapeutics.
    Khachigian LM
    Curr Opin Mol Ther; 2002 Apr; 4(2):119-21. PubMed ID: 12044032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNAzyme delivery systems: getting past first base.
    Tan ML; Choong PF; Dass CR
    Expert Opin Drug Deliv; 2009 Feb; 6(2):127-38. PubMed ID: 19239385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications.
    Ali MM; Aguirre SD; Mok WW; Li Y
    Methods Mol Biol; 2012; 848():395-418. PubMed ID: 22315083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic DNAzymes.
    Zhou W; Ding J; Liu J
    Theranostics; 2017; 7(4):1010-1025. PubMed ID: 28382172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNAzyme-based therapeutics for cancer treatment.
    Fu S; Sun LQ
    Future Med Chem; 2015; 7(13):1701-7. PubMed ID: 26381244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNAzymes: Expanding the Potential of Nucleic Acid Therapeutics.
    Larcher LM; Pitout IL; Keegan NP; Veedu RN; Fletcher S
    Nucleic Acid Ther; 2023 Jun; 33(3):178-192. PubMed ID: 37093127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of bcr-abl oncogene expression by novel deoxyribozymes (DNAzymes).
    Wu Y; Yu L; McMahon R; Rossi JJ; Forman SJ; Snyder DS
    Hum Gene Ther; 1999 Nov; 10(17):2847-57. PubMed ID: 10584930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deoxyribozymes as inhibitors of vascular smooth muscle cell growth.
    Khachigian LM
    Curr Pharm Biotechnol; 2004 Aug; 5(4):337-9. PubMed ID: 15320763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief communication: stability and catalytic activity of novel circular DNAzymes.
    Seifert G; Taube T; Paal K; von Einsiedel HG; Wellmann S; Henze G; Seeger K; Schroff M; Wittig B
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(7):785-93. PubMed ID: 16898416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribozymes as Catalytic Nanotherapeutic Agents.
    Khachigian LM
    Cancer Res; 2019 Mar; 79(5):879-888. PubMed ID: 30760521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Biosensing Applications of Diverse RNA-Cleaving DNAzymes.
    Liu M; Chang D; Li Y
    Acc Chem Res; 2017 Sep; 50(9):2273-2283. PubMed ID: 28805376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNAzymes and cardiovascular disease.
    Benson VL; Khachigian LM; Lowe HC
    Br J Pharmacol; 2008 Jun; 154(4):741-8. PubMed ID: 18454170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gaining target access for deoxyribozymes.
    Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
    J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of DNAzymes to cleave RNA in vivo is due to limited Mg[Formula: see text] concentration in cells.
    Victor J; Steger G; Riesner D
    Eur Biophys J; 2018 May; 47(4):333-343. PubMed ID: 29248953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Targeted DNAzyme-Nanocomposite Probe Equipped with Built-in Zn(2+) Arsenal for Combined Treatment of Gene Regulation and Drug Delivery.
    He ZM; Zhang PH; Li X; Zhang JR; Zhu JJ
    Sci Rep; 2016 Mar; 6():22737. PubMed ID: 26956167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oligodeoxyribozymes that cleave beta-catenin messenger RNA inhibit growth of colon cancer cells via reduction of beta-catenin response transcription.
    Choi BR; Gwak J; Kwon HM; Oh S; Kim KP; Choi WH; Cho YH; Kim DE
    Mol Cancer Ther; 2010 Jun; 9(6):1894-902. PubMed ID: 20501807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.